)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Centessa Pharmaceuticals
Centessa Pharmaceuticals (CNTA) investor relations material
Centessa Pharmaceuticals TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary3 Mar, 2026
Progress and strategic vision
ORX750 has advanced to patient studies, with registrational studies for rare hypersomnias planned to start this quarter.
The platform aims to deliver first-in-class treatments for NT2 and idiopathic hypersomnia, leveraging potent and selective orexin agonists.
Expansion into multiple neuropsych and neurodegenerative indications is planned, utilizing follow-up assets ORX142 and ORX489.
The company is transitioning toward a pre-commercial phase, preparing to hire a commercial team and enhance physician education.
A robust communication strategy is being developed to support upcoming registrational studies and commercial readiness.
Clinical data and development updates
November data showed best-in-class efficacy at low doses, with significant improvements in MWT and ESS, and strong cataplexy control.
Dose escalation has continued to explore maximum tolerated doses, aiming for optimal efficacy and tolerability.
Phase II updates in Q1 will focus on top-end efficacy and may include multiple indications, with registrational program design details.
Open label extension data show sustained efficacy with no degradation from two to four weeks, and high patient uptake.
No adverse events have limited the therapeutic index; insomnia is considered a marker for maximum tolerated dose.
Differentiation and competitive positioning
ORX750 is designed for once-daily dosing with linear PK, rapid onset, and flexibility for split dosing to enhance patient control.
Differentiation is driven by prolonged duration of action, normalization of wakefulness, and strong efficacy in both EDS and cataplexy.
Visual disturbances observed were mild, transient, and not dose-dependent; titration may further improve tolerability.
The company maintains strong alignment with FDA and regulatory bodies for its registration program.
Phase III design will incorporate creative features to fully explore the therapeutic index and maintain first-in-class positioning.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Centessa Pharmaceuticals earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
Centessa Pharmaceuticals
Next Centessa Pharmaceuticals earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company dedicated to discovering, developing, and delivering transformative medicines. Established in 2020, the company focuses on developing a wide range of innovative treatments across various therapeutic areas, including rare diseases and immuno-oncology. Centessa Pharmaceuticals is headquartered in Altrincham, United Kingdom, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage